Yaobin Ouyang

Sex-specific effects of gastrointestinal microbiome disruptions on Helicobacter pylori-induced gastric carcinogenesis in INS-GAS mice

Single-cell transcriptomic profiling uncovers cellular complexity and microenvironment in gastric tumorigenesis associated with Helicobacter pylori

The Protective Role of DDIT4 in Helicobacter pylori-induced Gastric Metaplasia Through Metabolic Regulation of Ferroptosis

Research trends on nanomaterials in gastric cancer: a bibliometric analysis from 2004 to 2023

YAP and β-catenin cooperate to drive <i>H. pylori</i> -induced gastric tumorigenesis

Fourteen-day vonoprazan and low- or high-dose amoxicillin dual therapy for eradicating Helicobacter pylori infection: A prospective, open-labeled, randomized non-inferiority clinical study

Vonoprazan and amoxicillin dual therapy as the first‐line treatment of <i>Helicobacter pylori</i> infection: A systematic review and meta‐analysis

Research trends on the relationship between gut microbiota and colorectal cancer: A bibliometric analysis

Research trends on artificial intelligence and endoscopy in digestive diseases: A bibliometric analysis from 1990 to 2022

Research trends on vonoprazan‐based therapy for <i>Helicobacter pylori</i> eradication: A bibliometric analysis from 2015 to 2023

Research trends on the relationship between <i>Helicobacter pylori</i> and microbiota: A bibliometric analysis

Optimization of vonoprazan‐amoxicillin dual therapy for eradicating <i>Helicobacter pylori</i>infection in China: A prospective, randomized clinical pilot study

Convergent dysbiosis of gastric mucosa and fluid microbiome during stomach carcinogenesis

Amoxicillin‐vonoprazan dual therapy for<scp><i>Helicobacter pylori</i></scp>eradication: A systematic review and meta‐analysis

Probiotics mitigate Helicobacter pylori‐induced gastric inflammation and premalignant lesions in INS‐GAS mice with the modulation of gastrointestinal microbiota

Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for Helicobacter pylori Eradication

Helicobacter pylori infection activates Wnt/β-catenin pathway to promote the occurrence of gastritis by upregulating ASCL1 and AQP5

Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis

Analysis of oral microbiota alterations induced by <i>Helicobacter pylori</i> infection and vonoprazan‐amoxicillin dual therapy for <i>Helicobacter pylori</i> eradication

Helicobacter pylori infection worsens impaired glucose regulation in high-fat diet mice in association with an altered gut microbiome and metabolome

MiR‐155 promotes colitis‐associated intestinal fibrosis by targeting HBP1/Wnt/β‐catenin signalling pathway

Activation of Aquaporin 5 by carcinogenic <i>Helicobacter pylori</i> infection promotes epithelial‐mesenchymal transition via the MEK/ERK pathway

<i>Helicobacter pylori</i> induces epithelial‑mesenchymal transition in gastric carcinogenesis via the AKT/GSK3β signaling pathway

Effect of <i>Helicobacter pylori</i> eradication on hyperplastic gastric polyps: A systematic review and meta‐analysis

Research Trends on Clinical <i>Helicobacter pylori</i> Eradication: A Bibliometric Analysis from 1983 to 2020

Reverse hybrid therapy for <i>Helicobacter pylori</i> eradication: A systematic review and meta‐analysis

The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances

Inhibition of autophagy aggravates DNA damage response and gastric tumorigenesis via Rad51 ubiquitination in response to <i>H. pylori</i> infection

Integrative Analysis of Differential lncRNA/mRNA Expression Profiling in Helicobacter pylori Infection-Associated Gastric Carcinogenesis

The eradication of <i>Helicobacter pylori</i> restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults